Regenerative Medical Solutions (RMS) continues to make strides toward its mission of curing diabetes. During a recent interview with Drew Mariani on Relevant Radio, RMS… Read More »RMS Launches Humanized Mouse Study, Marking a Major Milestone Toward a Diabetes Cure
We are proud to announce that we have secured a $1.8 million grant from the National Institutes of Health (NIH) to accelerate our development of… Read More »RMS Awarded $1.8M NIH Grant to Advance Groundbreaking Diabetes Cure
On September 19, 2025, our very own Tony Kolton, CEO of Regenerative Medical Solutions (RMS), joined Drew Mariani on Relevant Radio to share an inspiring… Read More »A Diabetes Cure is in Sight: Listen to Tony on Relevant Radio
Regenerative Medical Solutions has received approval from the Wisconsin Economic Development Corporation (WEDC) for a 25% state income tax credit for qualified investors. This incentive… Read More »RMS Secures 25% Wisconsin Tax Credit for Investors Supporting Breakthrough Diabetes Cure
Effective methods for diabetes management and cure.
Innovative solutions for Diabetes Management and Treatment
Regenerative Medical Solutions (RMS) was proud to attend the prestigious 43rd Annual J. P. Morgan Healthcare Conference in San Francisco, held from January 13-16, 2025.… Read More »Regenerative Medical Solutions Attends the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco
Regenerative Medical Solutions played a key role in the 5th Summit on Stem Cell-Derived Islets, held October 28-29, 2024, at Harvard University’s Joseph B. Martin… Read More »Regenerative Medical Solutions Sponsors 5th Summit on Stem Cell-Derived Islets at Harvard